As the U.S. IPO market opens back up, here’s how biotech CEO Marc de Garidel says business leaders can capitalize.

As of May 31, 2025, JBDI held cash and cash equivalents of $2.7 million, an increase from $0.2 million at the end of FY 2024, ...

In contrast, many companies that submitted guidance filings in 2022 and 2023 are still in the guidance filing stage.

No traditional IPOs are currently scheduled for the week ahead as the government shutdown continues to mostly pause new ...